Minerva Neurosciences, Inc.
NERV
$1.67
-$0.055-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.44M | -3.31M | -33.65M | -31.60M | -30.01M |
| Total Depreciation and Amortization | 5.60K | 5.60K | 5.60K | 5.60K | 5.60K |
| Total Amortization of Deferred Charges | 17.10K | 23.50K | 25.60K | 25.60K | 25.60K |
| Total Other Non-Cash Items | -20.69M | -18.14M | 10.59M | 10.59M | 10.25M |
| Change in Net Operating Assets | -320.60K | 1.05M | 2.20M | 222.60K | 4.94M |
| Cash from Operations | -19.55M | -20.38M | -20.83M | -20.76M | -14.78M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 20.00M | 20.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -86.70K | -396.30K | -396.30K |
| Cash from Financing | -- | 0.00 | -86.70K | 19.60M | 19.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.55M | -20.38M | -20.92M | -1.16M | 4.82M |